Business · 12/09/2002
FDA Releases Draft Guidance on Bioengineered Plant-Derived Products
The FDA, in collaboration with the USDA, has made available a draft document outlining recommendations for the use of bioengineered plants or plant materials to produce various biological products, including drugs and medical devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →